Assessing Physician Agreement in Biologic Therapy Initiation and Selection in Patients with Severe Asthma
Despite high internal consistency among individual clinicians, substantial variability exists between experts in the selection of biologic therapies for severe asthma. These findings underscore the need for comparative, head-to-head clinical trials to better guide biologic selection in patients eligible for multiple therapies.
Authors
- Agnes Hernandez Biette (ORCID: https://orcid.org/0000-0002-5965-4389)
- C. Rivera
- Mariana Muñoz‐Esquerre (ORCID: https://orcid.org/0000-0002-6747-7116)
- Leandro Tapia Barredo
- Pilar Ausín
- Ignasi Garcia-Olivé
- Magí Farré
- Xavier Muñoz-Gall
Institutions
- Universitat Autònoma de Barcelona (ES)
- Universitat Pompeu Fabra (ES)
- Bellvitge University Hospital (ES)
- Institut d'Investigació Biomédica de Bellvitge (ES)
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES)
- Vall d'Hebron Institut de Recerca (ES)
- Vall d'Hebron Hospital Universitari (ES)
- Hospital Del Mar (ES)
- Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (ES)
- Hospital Universitari Germans Trias i Pujol (ES)
- Universitat de Barcelona (ES)
Publication Details
- Journal
- Open Respiratory Archives
- Published
- 2026-02-26
- DOI
- https://doi.org/10.1016/j.opresp.2026.100604
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00